Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 177
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Psychedelic Policy Briefing: Week of July 6, 2026
Psychedelics Today at the Aspen Psychedelic Symposium
The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness
FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL
PT335 – Christopher Dawson & Andrew Galloway – Modernizing Traditional Plant...
Tripping the Reward Circuit: Psychedelics for Substance Use Disorders
Psychedelic Drugs Market Reaches US$6330.0 Mn by 2026 from US$3210.0 Mn...
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
Numinus to Host Q3 2022 Results Conference Call on July 14,...
Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate...
FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE
Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel...
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research...
Load more